The US Supreme Court in its Teva Pharmaceuticals USA v Sandoz ruling has outlined a new rule for the Federal Circuit when reviewing the underlying facts in a district court’s claim construction. One observer described it as “a ground shift, but not a true earthquake”
Unlock this content.
The content you are trying to view is exclusive to our subscribers.